First FDA Center Of Excellence For Regulatory Science Looks At Nanotechnology
This article was originally published in The Pink Sheet Daily
Executive Summary
National Center for Toxicological Research signs agreement setting up CERS in Arkansas.
You may also be interested in...
FDA Advisors Want More Data On Nanotech Sunscreens
Members of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology say more light needs to be shed on nanotechnology. FDA officials tell the panel the agency’s knowledge of pharmaceutical firms’ use of nanotechnology still is developing, but maintain the products are safe.
FDA Advisors Want More Data On Nanotech Sunscreens
Members of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology say more light needs to be shed on nanotechnology. FDA officials tell the panel the agency’s understanding of how pharmaceutical firms are using nanotechnology is still developing, but they maintain that currently marketed products are safe.
Foreign Regulator Exchange Program Contemplated By U.S. State Department
FDA has its own programs, but a State Department undersecretary said enhancing training at FDA could boost efforts to fight drug counterfeiting and diversion.